chr19-48048348-C-T
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_003706.3(PLA2G4C):c.1621G>A(p.Ala541Thr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000123 in 1,598,226 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 13/19 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_003706.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
PLA2G4C | NM_003706.3 | c.1621G>A | p.Ala541Thr | missense_variant | 17/17 | ENST00000599921.6 | NP_003697.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
PLA2G4C | ENST00000599921.6 | c.1621G>A | p.Ala541Thr | missense_variant | 17/17 | 1 | NM_003706.3 | ENSP00000469473.1 | ||
PLA2G4C | ENST00000594790.1 | n.374G>A | non_coding_transcript_exon_variant | 3/3 | 1 | |||||
PLA2G4C | ENST00000599111.5 | c.1651G>A | p.Ala551Thr | missense_variant | 17/17 | 2 | ENSP00000472546.1 | |||
PLA2G4C | ENST00000354276 | c.*80G>A | 3_prime_UTR_variant | 17/17 | 2 | ENSP00000346228.2 |
Frequencies
GnomAD3 genomes AF: 0.0000789 AC: 12AN: 152120Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000848 AC: 20AN: 235822Hom.: 0 AF XY: 0.0000936 AC XY: 12AN XY: 128176
GnomAD4 exome AF: 0.000127 AC: 184AN: 1446106Hom.: 1 Cov.: 30 AF XY: 0.000125 AC XY: 90AN XY: 719404
GnomAD4 genome AF: 0.0000789 AC: 12AN: 152120Hom.: 0 Cov.: 32 AF XY: 0.0000807 AC XY: 6AN XY: 74324
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Sep 14, 2022 | The c.1621G>A (p.A541T) alteration is located in exon 17 (coding exon 16) of the PLA2G4C gene. This alteration results from a G to A substitution at nucleotide position 1621, causing the alanine (A) at amino acid position 541 to be replaced by a threonine (T). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at